throbber
ACTA OPHTH ALMOLOGICA VOL. 58 1 980
`
`Department of Ophthalmology1 (Head: Henrik Forsius), University of Oulu, Oulu, Finland,
`The Applied Physics Laboratory2 (Head: Alexander Kossiakoff)
`and the Wilmer Ophthalmological Institute (Head: Amall Patz),
`of the Johns Hopkins University and Hospital, Baltimore, Maryland, USA.
`
`INDOCYANINE GREEN FLUORESCENCE ANGIOGRAPHY
`
`BY
`
`LEA HYVARINEN1 and ROBERT W. FLOWER2
`
`Indocyanine green (ICG) fluorescence angiography has been further refined
`for use in both laboratory and clinical investigations. In the present modifica­
`tion of the Zeiss fundus camera all lenses except the aspherical objective lens
`have been specially antireflection coated to increase light transmission in the
`spectral region around 800 nm. A 300 watt indium iodide lamp continuous
`light source has replaced the conventional xenon flash lamp. This light source
`produces a retinal irradiance of 265 mw, and therefore restricts retinal
`exposure time to 11.9 seconds, but that time is more than adequate to record
`passage of dye through the choroid. Spatial resolution of the fundus on the
`film has been increased from 11.7 microns to 7.4 microns.
`With these technical refinements the choroidal circulation can be studied at 20
`frames per second, which is adequate to document the very rapid movement of
`blood through the vasculature. ICG angiography may change our interpreta­
`tions of choroidal circulatory phenomena which are now based on fluorescein
`angiography, and it clearly is an effective tool in laboratory (experimental)
`investigations.
`
`Key words: indocyanine green fluorescence — angiographic studies of the eye -
`choroidal circulation.
`
`Sodium fluorescein angiography has been an important part of ophthalmology's
`armamemtarium for well over a decade now, and its clinical diagnostic value in
`retinal vascular diseases cannot be impugned. However, its usefulness in studying
`bloodflow dynamics is limited, especially in the choroid where transmission of
`visible light wavelengths is poor and extravasation of fluorescein dye readily occurs.
`
`Received December 7, 1979.
`
`528
`
` VISIONSENSE - 1014
` VISIONSENSE v.
` NOVADAQ TECHNOLOGIES
` Page 1 of 11
`
`

`

`ICG angiography
`
`There are even instances in which misinterpretation of fluorescein angiograms may
`have led to erroneous conclusions about choroidal bloodflow (Flower 1972, 1980).
`Development of indocyanine green (ICG) fluorescence angiography was initially
`persued solely as a way to obviate the limitations imposed by fluorescein dye during
`experimental studies of choroidal bloodflow dynamics. It was serendipitous that
`early on in development of the technique it became evident that ICG angiography
`could be used safely and routinely on human subjects as well. Clinical ICG
`angiography has been performed since about late 1973, and the data obtained have
`been invaluable to refinement of the technique. The accumulated angiographic
`material is still insufficient to warrant interpretation of choroidal circulatory
`phenomena in pathological conditions. However, some observations can be repor­
`ted.
`Both ICG absorption angiography and the early method of fluorescence choroi­
`dal angiography have been described in detail before (Flower 1972a,b; Flower &
`Hochheimer 1973, 1976; Flower 1976), therefore it is the refinements and resulting
`improvements in spatial and temporal resolution achieved since these which are
`described below.
`
`Technique
`
`During the development of the new camera for ICG angiography approximately
`150 ICG human angiograms were made at the University of Oulu, Department of
`Ophthalmology and 480 in the Wilmer Ophthalmological Institute. ICG and
`fluorescein angiograms were done a few minutes apart. Injection of ICG dye was
`made via a 3-way cannula followed immediately by a saline flush (Flower 1973). No
`allergic or vasovagal reactions occured, and none of the patients were discomforted
`by the illumination used for ICG near-infrared photography.
`220 ICG angiograms of rhesus monkeys were made at the Wilmer Ophthal­
`mological Institute. The injection technique was identical with that in human
`studies except that smaller volumes were injected, and all animals were anesthetized
`with halothane.
`Fluorescence ICG angiography is performed in much the same way as fluorescein
`angiography, the major difference being that ICG angiography utilizes near-
`infrared light wavelengths while fluorescein utilizes light wavelengths in the visible
`region of the spectrum. Descriptions of the absorption and emission ICG dye
`spectra as well as characteristics of the photographic film and excitation and barrier
`filters used in choroidal angiography have been previously published (Flower &
`Hochheimer 1973, 1976). Briefly, the advantages of ICG dye in choroidal angio­
`graphy are that there is no extravasation from the choriocapillaris, that it absorbs
`
`Acta ophthal. 58,4
`
`34
`
`529
`
` VISIONSENSE - 1014
` VISIONSENSE v.
` NOVADAQ TECHNOLOGIES
` Page 2 of 11
`
`

`

` VISIONSENSE - 1014
` VISIONSENSE v.
` NOVADAQ TECHNOLOGIES
` Page 3 of 11
`
`

`

`ICG angiography
`
`Graph indicating maximum level of safe retinal irradiance as a function of exposure time.
`
`light and fluoresces in a spectral region where retinal and choroidal pigments are
`fairly transparent, and that its long wavelengths of emitted light are more than six
`times less scattered by the ocular media than the shorter visible light wavelengths
`emitted by fluorescein. Its principal disadvantage is that it does not fluoresce
`efficiently. Whereas the quantam efficiency of fluorescein dye in blood is nearly I,
`that of ICG dye is only 0.13, and if the relative fluorescence intensity of fluorescein
`is arbitrarily set at 1, that of ICG is 25 times less. Therefore, developing the
`instrumentation for choroidal angiography essentially has been an exercise in
`optimizing ability to record the fluorescent light energy emitted by ICG dye in the
`ocular blood vessels.
`
`Fig. 2.
`Ten consecutive frames of a 20 frame per second ICG fluorescence angiogram made of an
`adult rhesus monkey. Arrows indicate the location of the same individual choroicapillaris
`lobule throughout the sequence. In frames A-D, the arterial feeder of the lobule can be
`identified. In frames D-F, to the left of the arrow, the drainage venules into which the lobule
`empties can be seen. Note that in frame A-F the lobule appears white as it fills with dye and
`then appears black in frames G-J where it has essentially emptied. Maximum filling of the
`lobule occurred by frame D, indicating a filling time of only 0.2 seconds.
`
`551
`
`34*
`
` VISIONSENSE - 1014
` VISIONSENSE v.
` NOVADAQ TECHNOLOGIES
` Page 4 of 11
`
`

`

`Lea Hyvarinen and Robert W. Flower
`
`The lenses of the fundus camera are normally antireflection coated to efficiently
`transmit light throughout the visible spectrum with maximum transmission oc­
`curring at about 530 nm wavelength. However, near 800 nm wavelength where
`ICG fluorescence occurs, the measured loss of light energy at each lens surface is
`about 4% (the loss nominally occuring at most wavelengths when uncoated lens
`elements are used). By antireflection coating lens elements specifically for 800 nm
`wavelength, this loss can be reduced to as little as 0.3% per lens surface. This was
`done to all lenses in the Zeiss fundus camera imaging optics except the aspherical
`objective lens which is normally uncoated. Providing one of the auxiliary accomoda­
`tion lenses is not used, there are 14 lens surfaces in the fundus camera imaging
`optics. At 800 nm wavelength, with the original lens coatings, total light transmission
`was 0.96014=0.560 or 56%; with proper antireflection coatings, total transmission
`became 0.99714=0.959 or 96% which amounts to 40% more light available to make
`film exposures.
`The effective aperture stop in the Zeiss camera is the hole drilled through the
`diagonal mirror located between the aspherical objective lens and the auxiliary lens
`wheel. Normally this hole is 5 mm in diameter, but by enlarging it to 1 cm, 4 times as
`much light can pass through the imaging optics to the photographic film.
`Reduction of this diagonal mirror surface which reflects light into the eye only
`results in an 11 % decrease of 800 nm wavelength excitation light energy, and that is
`regained by replacing the aluminum coatings on both diagonal mirrors in the
`illumination optics with quartz-clad silver. Added to the gain in transmission
`achived by using better lens coatings, a total gain of 5.7 times in light energy
`transmission at 800 nm wavelength makes it possible to photograph the choroid at
`the 2.5 times magnification of the standard Zeiss fundus camera.
`Of equal importance is improving temporal resolution of the rapid choroidal
`dye-filling sequence of events. Since no flash lamp light source is available which can
`be re-cycled at a sufficiently high rate and yet deliver enough light energy on each
`flash to perform ICG angiography, a continuous light source was installed. Initially,
`a 150 watt quartz halogen lamp was used, and in order to increase the available light
`intensity, an adjustable mirror was also installed behind the lamp. More recently we
`used a 300 watt indium iodide lamp which has a much larger in light energy
`component at 800 nm wavelength. Caution must be exercised in using such a
`continuous light source to insure that retinal irradiance does not exceed a safe level.
`For the approximate 35 degree fundus area illuminated by the Zeiss fundus camera
`and for the light wavelengths required to excite ICG dye to fluorescence, the
`maximum permissible exposure of the retina is 3160 mw-seconds (American
`National Standard for the safe use of lasers 1973). Retinal irradiance is shown as a
`function of continuous exposure time in Fig. 1. The indium iodide light source
`produces a retinal irradiance of 265 mw, consequently, an exposure time of no
`
`532
`
` VISIONSENSE - 1014
` VISIONSENSE v.
` NOVADAQ TECHNOLOGIES
` Page 5 of 11
`
`

`

`Fig. 3.
`ICG-angiograms with unusually good visibility of both arteries (A, B) and veins of choroid (C, D).
`
`533
`
` VISIONSENSE - 1014
` VISIONSENSE v.
` NOVADAQ TECHNOLOGIES
` Page 6 of 11
`
`

`

`Lea Hyvarinen and Robert W. Flouier
`
`more than 11.9 seconds is permitted, but this is more than adequate to record the
`passage of dye through the choroidal circulation.
`The brighter light source coupled with improved light transmission efficiency of
`the camera optics makes it easy to now record angiograms at rates up to 20 per
`second; this compares favorably with the 4 or 5 frames per second previously
`achieved. At the same time, spatial resolution of the fundus on film was increased
`from 11.7 microns to 7.4 microns which is nearly equal to that theoretically
`achieved in fluorescein angiography.
`During the development of the new camera several hundred angiograms, were
`made to test the different improvements and the clinical application of the method.
`In these angiograms a number of interesting phenomena were recorded, some of
`which are reported in this paper.
`
`Results
`
`Animal experiments
`We have recently succeeded in photographing the passage of ICG dye through the
`choroid at 20 frames per second. The ten consecutive frames in Fig. 2 permit
`visualization of a sharp dye wavefront moving through the entire choroidal
`vasculature of an adult rhesus monkey eye following retrograde injection of less
`than 0.05 ml of dye into the contralateral common carotid artery. They indicate
`that the average time required for dye transit across individual choriocapillaris
`lobules is on the average 1/5 second. The dye wavefront may be easily followed in
`the particular lobule indicated by the arrow throughout the sequence. This series of
`angiograms and others made the same way confirm and even refine choriocapillaris
`bloodflow measurements made earlier. But more significantly, in the context of the
`present paper, they demonstrate the necessity for using high speed angiography to
`study the choroidal circulation. Obviously, subtle changes in choroidal bloodflow
`could be completely missed in angiograms of less temporal or spatial resolution.
`
`Human Studies
`Although the choroid is nearly transparent to both those wavelengths of light used
`to excite ICG dye to fluorescence and those emitted by the dye, there was a wide
`variation in visibility of choroidal vessels among different individuals. The reasons
`for this variation are not apparent; choroidal vessels were quite often very poorly
`visualized in young healthy persons with no known choroidal pathology, yet poor
`visibility was not due simply to poor photographic technique/resolution of visible
`details was good. In less than one-third of the angiograms were choroidal vessels
`seen as clearly as those in Fig. 3 where both the short ciliary arteries and their
`
`534
`
` VISIONSENSE - 1014
` VISIONSENSE v.
` NOVADAQ TECHNOLOGIES
` Page 7 of 11
`
`

`

`ICG angiography
`
`Fig. 4.
`ICG is more reliable than fluorescein for measurement of dye appearance time in choroid,
`but ICG fluorescence is also attenuated by the pigment. Note that the fluorescence intensity
`of dye in the cilioretinal artery (era) is higher than in nearby choroidal vessels although dye
`concentrations in these vessels most probably are identical.
`
`branches and later the choroidal veins are well defined; smaller wein branches and
`choriocapillaris are not visualized.
`For measurement of dye appearance time in the choroidal vasculature, ICG is
`more reliable than fluorescein because it is more easily seen through the retinal and
`choroidal pigment, and it does not become extravasated. ICG fluorescence,
`however, can be attenuated by pigment as demonstrated in Fig. 4. First appearance
`of dye traces in the cilioretinal artery is seen in the frame preceeding Fig. 4, whereas
`the retinal vessels are barely visible. Note that the fluorescence itensity of dye in the
`cilioretinal artery is higher than that in the nearby choroidal vessels although dye
`concentration in both these vessels would be expected to be nearly identical.
`Blockage of ICG fluorescence is similar to that observed with fluorescein; blood
`or pigment clumps in retina can produce distinct areas of reduced or non-
`fluorescence in angiograms; similarly, the egg-yolk substance in Best’s disease
`blocks choroidal ICG fluorescence. But on the other hand, ICG angiography does
`
`535
`
` VISIONSENSE - 1014
` VISIONSENSE v.
` NOVADAQ TECHNOLOGIES
` Page 8 of 11
`
`

`

`In ICG-angiograms (A, B) there is an area of decreased dye fluorescence (arrow) which is not
`detectable in corresponding fluorescein angiograms (C, D). Times measured From the first
`appearance of the dye: 1,6 seconds (A, C), 3.2 seconds (B, D,).
`
` VISIONSENSE - 1014
` VISIONSENSE v.
` NOVADAQ TECHNOLOGIES
` Page 9 of 11
`
`

`

`ICG angiography
`
`Fig, 6
`A: Fluorescein angiogram of a large submacular neovascularization with a large feeding
`artery (arrow). The draining vein wraps around the artery, and its proximal part cannot be
`seen because of diffuse fluorescence near the disc.
`B: In the ICG-angiogram the vein is seen not to follow the artery to the disc margin and thus
`photocoagulation was placed close to the edge of the disc.
`
`sometimes reveal circulatory changes in choroid which are not detectable in
`corresponding fluorescein angiograms because of the masking effect of fluorescein
`which diffuses from the choriocapillaris into the intervascular space (Flower et al.
`1977; Hyvarinen & Maumenee 1971). Figs. 5A and 5B show an area of delayed
`filling in the choroid, but in corresponding fluorescein angiograms (Figs. 5C and
`5D) no such area of delayed filling is detectable.
`So far ICG angiography has not been used for clinical diagnosis, but the findings
`have occasionally affected clinical decisions. In Fig. 6A a large submacular neovas­
`cularization with a large feeding artery is shown. The draining vein could not be
`seen in the fluorescein angiograms clearly enough to warrant photocoagulation of
`the feeder at the disc margin. In the ICG angiogram (Fig. 6B) the vein can be seen
`to follow the artery only half way to the disc. Based upon this observation,
`photocoagulation was made at the disc margin and the neovascularization collapsed
`without danger of venous bleeding.
`
`537
`
` VISIONSENSE - 1014
` VISIONSENSE v.
` NOVADAQ TECHNOLOGIES
` Page 10 of 11
`
`

`

`Lea IIyvdrinen and Robert W. Flower
`
`Discussion
`
`Development of ICG angiography has been ongoing for several years. The earlier
`method which used adaptors and an otherwise unmodified Zeiss fundus camera has
`given some insight into the choroidal circulation (Craandijk 8c Van Beek 1976;
`Forsius et al. 1977). The technical refinements now make possible high-speed
`choroidal angiography in clinical investigations. Before it can be used as a
`diagnostic tool, however, a fairly large number of studies are needed to develop the
`basic interpretations of different circulatory patterns. At the present time ICG
`angiography has already demonstrated that fluorescein angiography can give a
`false impression of circulatory status in some clinical conditions.
`
`References
`
`American National Standard for the Safe Use of Lasers, publication ANSI Z136.1-1973
`(1973) by the American National Standards Institutes, Inc., New York.
`Craandijk A. & Van Beek C. A. (1976) Indocyanine green fluorescence angiography of the
`choroid. Brit.J. OphthaL 60, 377—385.
`Flower R. W, (1972a) Infrared absorption angiography of the choroid and some observations
`on the effects of high intraocular pressures. Amer.J. Ophthal. 74, 600—614.
`Flower R. W. (1972b) Simple adaptors for fast conversion of a fundus camera for
`rapidsequence ICG fluorescence choroidal angiography./. Brit. Photog. Assoc. 45, 43-47.
`Flower R. W. 8c Hochheimer B. F. (1973) A clinical technique and apparatus for simultaneous
`angiography of the separate retinal and choroidal circulations. Invest. Ophthal. 12,248—261.
`Flower R. W. (1973) Injection technique for indocyanine green and sodium fluorescein dye
`angiography of the eye. Invest. Ophthal. 12, 881—895.
`Flower R. W. & Hochheimer B. F. (1976) Indocyanine green dye fluorescence and infrared
`absorption choroidal angiography performed simultaneously with fluorescein angiography.
`Johns Hopkins Med. J. 138, 33-42.
`Flower R. W. (1976) High Speed human choroidal angiography using indocyanine green dye
`and a continuous light source. In: DeLaey J. J. (Ed.). International Symposium on
`Fluorescein Angiography. Documenta Ophthalmologica Proceedings Series, Vol. 9, pp.
`59—64. Dr. W. Junk bv., the Hague,
`Flower R. W., Speros P. 8c Kenyon K. R. (1977) Electroretinographic changes and choroidal
`defects in a case of central retinal artery occlusion. Amer.J. Ophthal. 83, 451—459.
`Flower R. W. (1980) Choroidal fluorescent dye filling patterns: a comparison of high speed
`ICG and fluorescein angiograms (To be published).
`Forsius H., Hyvarinen L., Nieminen H. 8c Flower R. W. (1977) Fluorescein and indocyanine
`green fluorescence angiography in study of affected males and in female carriers with
`choroideremia. Acta ophthal. (Kbh.) 55, 459—470.
`Hyvarinen L. & Maumenee A. E. (1971) Interpretation of choroidal fluorescence. Amalric,
`P., (Ed.). Proc. int. Symp. Fluorescein Angiography, Albi (1969) pp. 183—188. S. Krager.
`Basel, New York.
`
`Author’s address:
`R. Flower, Applied Physics Laboratory, Johns Hopkins Road, Laurel, Maryland 20810, USA.
`
` VISIONSENSE - 1014
` VISIONSENSE v.
` NOVADAQ TECHNOLOGIES
` Page 11 of 11
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket